fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

How the Oath to Society underpins clinical pharmacy practice

Written by | 13 Aug 2023

The Oath to Society, jointly developed by ESCP and EAHP underpins clinical pharmacy services and highlights pharmacists’ work to those outside the profession, according to ESCP President, Professor… read more.

Building best practice in clinical pharmacy

Written by | 12 Aug 2023

ESCP recognises that the translation of academic evidence into day-to-day practice is an important step in the development of clinical pharmacy services – and ESCP Best Practice papers… read more.

How ESCP special interest groups forge worldwide links

Written by | 11 Aug 2023

ESCP is a dynamic organisation that responds to the needs of its members and in doing so it has undertaken a number of key developments in recent years,… read more.

Why join the European Society for Clinical Pharmacy?

Written by | 10 Aug 2023

‘Innovations in Clinical Pharmacy Practice, Education and Research’ will be the topic of the forthcoming ESCP Symposium, to be held in Aberdeen, Scotland in Autumn 2023.  IMI spoke… read more.

Pharmacogenomics and personalised medicine in practice

Written by | 29 Jul 2023

Pharmacogenomics and personalised medicine are increasingly becoming a part of mainstream healthcare and it is an area where pharmacists have a major part to play. In this series… read more.

The challenges of developing pharmacogenomic services

Written by | 28 Jul 2023

Recent research has demonstrated the value of pharmacogenomics-guided prescribing but this is a far cry from the implementation of routine services. Dr Raliate Onatade Chief Pharmacist for North… read more.

How does pharmacogenomics work in day-to-day practice?

Written by | 27 Jul 2023

A number of examples show how pharmacogenetic testing is being integrated into day-to-day practice and helping to improve the safe and effective use of medicines, Raliat Onatade, Chief… read more.

The added value of pharmacogenomics to prescribing

Written by | 26 Jul 2023

Raliat Onatade, Chief Pharmacist for North Thames Genomic Medicines Service Alliance, recently gave the opening keynote address at the EAHP Congress in Lisbon (March 2023) on the subject… read more.

A holistic approach to drug therapy for heart failure

Written by | 8 Jul 2023

A recent publication described the holistic approach to drug therapy in a patient with heart failure – an area where treatment has changed considerably over the past 30… read more.

Who should oversee heart failure management?

Written by | 7 Jul 2023

The management of heart failure treatment is probably best done by a primary care team and pharmacists can play a major role in prescribing, says Paul Forsyth, Lead… read more.

What are the key challenges in the treatment of heart failure?

Written by | 6 Jul 2023

The key challenges in heart failure treatment include reaching the target dose, awareness of drug-specific issues that influence effectiveness and tackling adherence problems, according to Paul Forsyth, Lead… read more.

How should the four pillars of therapy for heart failure be prescribed?

Written by | 5 Jul 2023

Current thinking advocates the use of ‘four pillars of heart failure therapy’. Paul Forsyth, Lead Pharmacist, Clinical Cardiology at NHS Greater Glasgow and Clyde, explains how this treatment… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.